A new generation of tuberculosis drugs
09 February 2012
Scientists in India are targeting enzymes responsible for catalysing the formation of bonds to repair nicks in the phosphodiester backbone of DNA - called DNA ligases - to tackle the ever-growing health concern of multi-drug resistant bacteria, in particular against tuberculosis.
Unlike current drugs, the new compound targets just the bacterial enzymes instead of both bacterial and human enzymes
The team from the Central Drug Research Institute in Lucknow synthesised and screened drugs from aryl hydroxamates to show that they were active against bacterial, but not human, versions of DNA ligase, as well as concluding that they did not have any general DNA interactions.
'Hydroxamates offer a better chance to develop new economical anti-tuberculosis drugs. The ease of synthesis makes them attractive,' says Rama Pati Tripathi, part of the team in Lucknow.
'Developing new small molecule compounds that are able to distinguish between ATP- and NAD+-dependent ligases, such as the compounds presented here, is important for engineering molecules with increased levels of specificity,' says Rommie Amaro, an expert on enzymological and drug discovery studies at the University of California, Irvine, US. 'Such specificity is critical for these compounds to be useful from a clinical perspective. ' He adds that the work could help develop compounds that are active against RNA editing ligases. These are potential antiparasitic targets for several of the world's most devastating diseases, such as Chagas disease and African sleeping sickness.
Interesting? Spread the word using the 'tools' menu on the left.
ReferencesV Kukshal et al, Med. Chem. Commun., 2012, DOI: 10.1039/c2md00168c
Also of interest
06 March 2011
A simple sugar can be used to label and monitor tuberculosis in the body and could form the basis of a whole body imaging agent in the future
17 September 2009
Small molecule inhibitor of tuberculosis protein complex offers a new strategy to attack the disease
28 November 2008
Explosive mode of action for experimental TB treatment revealed
Comment on this story at the Chemistry World blog
Read other posts and join in the discussion
External links will open in a new browser window